So, in late October we get revenue figures from Dx and SleepCheck. And people are sprouting all sorts of expectations. But we don’t have any firm, logical foundation by which to make an informed assessment as to the ‘number’. I am also worried that management will just lump the entire 3 months number in one hit, whereas having month by month numbers will demonstrate (hopefully) growth. Shouldn’t some professional body like Morgans, or others make some guidance so then the figures are released we have a firm footing to judge performance. Or doesn’t that happen in the spec end of the market?
RAP Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
